Stocks
Incyte CorporationINCY
NASDAQHealthcareBiotechnology$92.54+0.55%
A biotechnology company focused on developing and commercializing small‑molecule drugs, primarily in oncology and inflammatory diseases. Its flagship product, Jakafi, is a leading treatment for myelofibrosis and other blood disorders and generates the majority of revenue, while a broader pipeline ta...
Market Cap: $18.4B52W Range: $53.56 – $112.29
Congressional Interest in Incyte Corporation (INCY)
9 members of Congress have disclosed 25 trades in Incyte Corporation (INCY), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 12 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
25
Unique Politicians
9
Buys
13
Sells
12
Who in Congress Is Trading INCY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-30 | Rohit Khanna | buy | $1K – $15K |
| 2026-03-10 | Rohit Khanna | buy | $1K – $15K |